As the pharmaceutical market in Asia Pacific countries becomes increasingly competitive, it appears many companies are resorting to bribery and payoffs to maintain a foothold in the region. This week China announced it is expanding a corruption investigation of pharmaceutical company GlaxoSmithKline, to include at least four other multinational drugmakers. In this particular case, police … Continue reading Lessons from GlaxoSmithKline: Understanding the Foreign Corrupt Practices Act